3,3',5-triiodothyronamine has been researched along with 3-iodothyronamine in 1 studies
Studies (3,3',5-triiodothyronamine) | Trials (3,3',5-triiodothyronamine) | Recent Studies (post-2010) (3,3',5-triiodothyronamine) | Studies (3-iodothyronamine) | Trials (3-iodothyronamine) | Recent Studies (post-2010) (3-iodothyronamine) |
---|---|---|---|---|---|
26 | 1 | 8 | 98 | 0 | 75 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Bandini, L; Frascarelli, S; Ghelardoni, S; Lorenzini, L; Sacripanti, G; Zucchi, R | 1 |
1 other study(ies) available for 3,3',5-triiodothyronamine and 3-iodothyronamine
Article | Year |
---|---|
3-Iodothyronamine and 3,5,3'-triiodo-L-thyronine reduce SIRT1 protein expression in the HepG2 cell line.
Topics: Animals; Cell Survival; Cells, Cultured; Down-Regulation; Hep G2 Cells; Humans; Mitochondrial Proteins; Rats; Rats, Wistar; Sirtuin 1; Sirtuins; Thyronines; Triiodothyronine | 2020 |